ArcherDX Personalized Cancer Monitoring Technology Designated by FDA as Breakthrough Device January 14, 2020
Calithera Biosciences Provides Overview of 2020 Corporate Milestones and Financial Guidance January 14, 2020
Verastem Oncology Announces Global Licensing Agreement with Chugai Pharmaceutical Co., Ltd. January 8, 2020
Bicycle Therapeutics and Cancer Research UK to Collaborate on Development of New Bicycle Immuno-oncology Candidate January 7, 2020
